Rockefeller Capital Management L.P. Nevro Corp Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$40.66 - $53.03 $25,331 - $33,037	-623 Reduced 99.84%	1 $0
Q2 2022 Aug 12, 2022	BUY	$40.85 - $77.67 $20,465 - $38,912	501 Added 407.32%	624 $27,000
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $539 - $828	9 Added 7.89%	123 $8,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $9,160 - $13,705	113 Added 11300.0%	114 $9,000
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $713 - $1,164	-7 Reduced 87.5%	1 $0
Q2 2021 Aug 10, 2021	BUY	$141.6 - $179.06 $1,132 - $1,432	8 New	8 $1,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.